Atlas Trials

A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC

Clinical trial NCT06503042 · UNKNOWN

Trial details

NCT number
NCT06503042
Sponsor
Tang-Du Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer
Start date
2024-08-01
Primary completion
2026-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.